Table 1.
Characteristic | n | % |
Number of patients | 420 | 100 |
Mean age in years (range) | 59.0 (23.3–91.6) | |
Tumour size | ||
T1 | 221 | 53 |
T2 | 166 | 39 |
T3 | 23 | 6 |
T4 | 10 | 2 |
Lymph node status | ||
Negative | 247 | 59 |
Positive | 166 | 39 |
Unknown | 7 | 2 |
Stage | ||
I | 163 | 39 |
II | 212 | 50 |
III | 38 | 9 |
Unknown | 7 | 2 |
Histological type | ||
Ductal | 273 | 65 |
Lobular | 65 | 15 |
Other | 82 | 20 |
Histological grade | ||
I | 108 | 26 |
II | 192 | 46 |
III | 120 | 28 |
ER status | ||
Positive | 323 | 77 |
Negative | 95 | 22 |
Data not available | 2 | 1 |
PR status | ||
Positive | 261 | 62 |
Negative | 157 | 37 |
Data not available | 2 | 1 |
Menopausal status | ||
Premenopausal | 132 | 31 |
Postmenopausal | 288 | 69 |
Recurrence at 5 years | ||
No | 344 | 82 |
Yes | 76 | 18 |
Cause of death at 5 years | ||
Alive | 334 | 79 |
Breast cancer | 50 | 12 |
Other | 36 | 9 |
ER, oestrogen receptor; PR, progesterone receptor.